Literature DB >> 23449681

Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India.

R Mohamudha Parveen1, Subha Manivannan, B N Harish, S C Parija.   

Abstract

Data on CTX-M type extended-spectrum β-lactamase (ESBL) produced by Gram-negative bacteria by molecular methods are limited from India. This study was conducted to investigate the prevalence of CTX-M type ESBL producing Escherichia coli and Klebsiella pneumoniae from nosocomial isolates in a tertiary care hospital in southern India. A total of 179 clinical isolates of K. pneumoniae (n = 72) and E. coli (n = 107) were obtained in a period of 3 months and assessed for ESBL production phenotypically. Associated resistance to a panel of antibiotics and Minimum Inhibitory Concentration for 3rd generation cephalosporins was determined. Phenotypically ESBL positive isolates were subjected to PCR for blaCTX-M gene using two sets of primers for the simultaneous detection of all the five major groups of CTX-M types. All the positive isolates were then subjected to a group specific PCR to detect the prevalent group. Out of 179 isolates, 156 (87.1%) were positive for ESBL phenotypically, which includes 39.2% of K. pneumoniae and 60.8% of E. coli. All of them were examined by PCR using two primers for the presence of blaCTX-M genes. Among the 156 phenotypic positive isolates, 124 (79.4%) were positive for blaCTX-M genes, of which 45 (36.2%) were K. pneumoniae, 79 (63.7%) were E. coli. When the 124 positive clinical isolates were further tested with CTX-M group-specific primers, all were positive for the CTX-M-1 group. Our findings document evidence of the high prevalence of multidrug resistant CTX-M group 1 type ESBL among nosocomial isolates in this region. High co-resistance to other non-β-lactam antibiotics is a major challenge for management of ESBL infections. This is alarming and calls for the judicious use of carbapenems, especially in developing countries. This has significant implications for patient management, and indicates the need for increased surveillance and for further molecular characterization of these isolates.

Entities:  

Keywords:  Antibiotic resistance; CTX-M types; Extended spectrum β-lactamase; Nosocomial isolates; South India

Year:  2011        PMID: 23449681      PMCID: PMC3298595          DOI: 10.1007/s12088-011-0140-3

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  22 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae.

Authors:  Sumeeta Khurana; Neelam Taneja; Meera Sharma
Journal:  Indian J Med Res       Date:  2002-10       Impact factor: 2.375

3.  Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.

Authors:  Johann D D Pitout; Ashfaque Hossain; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 4.  Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Authors:  Johann D D Pitout; Patrice Nordmann; Kevin B Laupland; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

5.  Comment on: Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.

Authors:  T R Walsh; M A Toleman; R N Jones
Journal:  J Antimicrob Chemother       Date:  2007-02-08       Impact factor: 5.790

6.  Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae.

Authors:  J D D Pitout; N Hamilton; D L Church; P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2007-03       Impact factor: 8.067

7.  Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Tomonari Yamashita; Koichi Shimakawa; Toshiro Ura; Hisaaki Nishio; Kaori Satoh; Ryoudou Washidu; Shohiro Kinoshita; Masanori Aihara
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

8.  Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.

Authors:  Yves De Gheldre; Véronique Avesani; Catherine Berhin; Michel Delmée; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2003-09-12       Impact factor: 5.790

9.  Molecular characterization of nosocomial CTX-M type beta-lactamase producing Enterobacteriaceae from a tertiary care hospital in south India.

Authors:  S A Jemima; S Verghese
Journal:  Indian J Med Microbiol       Date:  2008 Oct-Dec       Impact factor: 0.985

10.  Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David Boyd; Marianna Ofner-Agostini; Sara Christianson; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more
  5 in total

1.  Whole Genome Characterization of the High-Risk Clone ST383 Klebsiella pneumoniae with a Simultaneous Carriage of blaCTX-M-14 on IncL/M Plasmid and blaCTX-M-15 on Convergent IncHI1B/IncFIB Plasmid from Egypt.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Microorganisms       Date:  2022-05-26

2.  A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.

Authors:  Saswati Datta; Subhasree Roy; Somdatta Chatterjee; Anindya Saha; Barsha Sen; Titir Pal; Tapas Som; Sulagna Basu
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

3.  Occurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae.

Authors:  Amitabha Mondal; Manjunath Venkataramaiah; Govindan Rajamohan; Vijaya Bharathi Srinivasan
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

4.  Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka.

Authors:  Sridhar Pn Rao; Prasad Subba Rama; Vishwanath Gurushanthappa; Radhakrishna Manipura; Krishna Srinivasan
Journal:  J Lab Physicians       Date:  2014-01

Review 5.  Antimicrobial Resistance in Agri-Food Chain and Companion Animals as a Re-emerging Menace in Post-COVID Epoch: Low-and Middle-Income Countries Perspective and Mitigation Strategies.

Authors:  Samiran Bandyopadhyay; Indranil Samanta
Journal:  Front Vet Sci       Date:  2020-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.